Tweetorial coming up.. 🧵 #AskRenal #NSMC #MedTwitter #NephTwitter
Why does hypophosphatemia (serum phosphorus ˂2.5 mg/dL) happen in patients with cancer?
Why does hypophosphatemia (serum phosphorus ˂2.5 mg/dL) happen in patients with cancer?
Around 85% of phosphate is reabsorbed in the proximal tubule through secondary active transport.
5–20% of filtered phosphate (13 mg/kg/day) is eventually excreted in the urine.
⁉️What transporters reabsorb phosphate?
5–20% of filtered phosphate (13 mg/kg/day) is eventually excreted in the urine.
⁉️What transporters reabsorb phosphate?
When pseudohypophosphatemia is excluded, we think about hypophosphatemia in 3 etiologies:
🔹Decreased PO intake
🔹Losses (renal and GI)
🔹Decreased intestinal absorption.
🔹Decreased PO intake
🔹Losses (renal and GI)
🔹Decreased intestinal absorption.
We can follow the below algorithm from @CKJsocial that simplifies etiologies of hypophosphatemia.
Oncogenic osteomalacia:
tumors secrete FGF-23 and cause hypophosphatemia through renal phosphate wasting. Chronic hypophosphatemia leads to osteomalacia that appears as osteopenia and pseudofractures on radiographs.
Image from: radiologymasterclass.co.uk
tumors secrete FGF-23 and cause hypophosphatemia through renal phosphate wasting. Chronic hypophosphatemia leads to osteomalacia that appears as osteopenia and pseudofractures on radiographs.
Image from: radiologymasterclass.co.uk
Loading suggestions...